Literature DB >> 19427061

Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.

Mei Yue1, Amanda Hanna, Judith Wilson, Hanno Roder, Christopher Janus.   

Abstract

Abnormal phosphorylation of tau protein is a common event in many neurodegenerative disorders, including Alzheimer's disease and other tauopathies. We investigated the relationship between hyperphosphorylated tau in brain extracts and mnemonic functions in rTg4510 mouse model of tauopathy. We report that rTg4510 mice showed rapid deterioration in spatial learning and memory, which paralleled a significant increase of hyperphosphorylated tau in the brain between 3 and 5.5 months of age. At 5.5 months, rTg4510 females showed significantly higher levels of hyperphosphorylated tau than males, with no evidence of differential tau transgene expression between the sexes. The increased levels of hyperphosphorylated tau in females were associated with more severe impairment in spatial learning and memory as compared to transgenic males. We also showed that within studied age range, the decrease in memory performance was accompanied by other behavioral disturbances in the water maze related to search strategy, like thigmotaxic swim and cue response. These findings suggest that the onset of abnormal tau biochemistry and coincident cognitive deficits in the rTg4510 mouse model is sex-dependent with females being affected earlier and more aggressively than males.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427061     DOI: 10.1016/j.neurobiolaging.2009.04.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  40 in total

1.  Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia.

Authors:  Casey Cook; Judy H Dunmore; Melissa E Murray; Kristyn Scheffel; Nawsheen Shukoor; Jimei Tong; Monica Castanedes-Casey; Virginia Phillips; Linda Rousseau; Michael S Penuliar; Aishe Kurti; Dennis W Dickson; Leonard Petrucelli; John D Fryer
Journal:  Neurobiol Aging       Date:  2013-12-26       Impact factor: 4.673

2.  Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment.

Authors:  Daniel S Weitzner; Elizabeth B Engler-Chiurazzi; Linda A Kotilinek; Karen Hsiao Ashe; Miranda Nicole Reed
Journal:  J Vis Exp       Date:  2015-06-22       Impact factor: 1.355

3.  Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.

Authors:  Alessandro Didonna; Ester Cantó; Hengameh Shams; Noriko Isobe; Chao Zhao; Stacy J Caillier; Carlo Condello; Hana Yamate-Morgan; Seema K Tiwari-Woodruff; Mohammad R K Mofrad; Stephen L Hauser; Jorge R Oksenberg
Journal:  J Autoimmun       Date:  2019-04-19       Impact factor: 7.094

Review 4.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

5.  The effect of brief neonatal cryoanesthesia on physical development and adult cognitive function in mice.

Authors:  Christopher Janus; Todd Golde
Journal:  Behav Brain Res       Date:  2013-11-14       Impact factor: 3.332

6.  Effect size of memory deficits in mice with adult-onset P301L tau expression.

Authors:  Holly C Hunsberger; Carolyn C Rudy; Daniel S Weitzner; Chong Zhang; David E Tosto; Kevin Knowlan; Ying Xu; Miranda N Reed
Journal:  Behav Brain Res       Date:  2014-07-06       Impact factor: 3.332

7.  Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.

Authors:  Shu-Sheng Jiao; Xian-Le Bu; Yu-Hui Liu; Chi Zhu; Qing-Hua Wang; Lin-Lin Shen; Cheng-Hui Liu; Ye-Ran Wang; Xiu-Qing Yao; Yan-Jiang Wang
Journal:  Neurotox Res       Date:  2015-12-26       Impact factor: 3.911

Review 8.  Sex differences in Alzheimer's disease: Understanding the molecular impact.

Authors:  Carlos A Toro; Larry Zhang; Jiqing Cao; Dongming Cai
Journal:  Brain Res       Date:  2019-05-23       Impact factor: 3.252

9.  Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.

Authors:  Shalini S Rao; Larissa Lago; Irene Volitakis; Jay J Shukla; Gawain McColl; David I Finkelstein; Paul A Adlard
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

10.  Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.

Authors:  Jack A Wells; Holly E Holmes; James M O'Callaghan; Niall Colgan; Ozama Ismail; Elizabeth Mc Fisher; Bernard Siow; Tracey K Murray; Adam J Schwarz; Michael J O'Neill; Emily C Collins; Mark F Lythgoe
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.